Risks associated with COVID-19 severity
Severe SARS-CoV-2 Appears to Infect Coronary Vessels
SARS-CoV-2 targets plaque macrophages, and its entry is increased in cholesterol-loaded primary macrophages
In Early Trial, Results Promising for Moderna Combo COVID-Flu Vaccine
Moderna hopes to get federal regulatory approval for the combined vaccine in 2025
CDC Stops Issuing New COVID-19 Vaccination Cards
The cards people have at home can still be used as proof of vaccination
Nirmatrelvir/Ritonavir Cuts COVID-19 Complications in Highest-Risk Patients
Risk for COVID-19 hospitalization or death reduced for those who were severely or moderately immunocompromised
In-Hospital Mortality Evaluated for SARS-CoV-2-Linked Sepsis
March 2020 to November 2022 saw decline in crude in-hospital mortality for SARS-CoV-2-linked sepsis from 33.4 to 14.9 percent
COVID-19 Infection, Vaccination Have Little Effect on Migraine Worsening
Increased concern about migraine worsening was risk factor for perceived migraine worsening
FDA Approves Updated Novavax COVID-19 Vaccine
Updated shot is expected to better target variants that are circulating now and help prevent hospitalization and death from the virus
Maternal Psychosocial Stress, COVID-19 Infection Tied to Infant Attentional Processing
Findings revealed lower infant attention scores at six months, which predicted socioemotional function, neurodevelopmental risk
Maternal COVID-19 Vaccination Provides Some Protection for Infants
Some protection against COVID-19-related hospitalizations seen among infants, especially those aged younger than 3 months